BWA
SCPH

BDO Wealth Advisors’s scPharmaceuticals SCPH Stock Holding History

BDO Wealth Advisors’s Portfolio SCPH Stock Details SCPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		$4.33K Buy
+425
New +$4.43K ﹤0.01% 785

Other funds holding SCPH

O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
ACM
AIGH Capital Management Baltimore, Maryland $733M AUM 327.32% 1-Year Est. Return
CAC
Cowen and Company New York $2.97B AUM 105.26% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
5VM
5AM Venture Management San Francisco, California $360M AUM 345.76% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BDO Wealth Advisors's SCPH Position: Q2 2023 in Review

BDO Wealth Advisors opened a new position in scPharmaceuticals (SCPH) in Q2 2023: 425 shares worth $4.33K. The stake represents ﹤0.01% of the portfolio and ranks #785 among its holdings.

81 funds tracked by Wall St. Rank hold SCPH as of Q2 2023.

  • BDO Wealth Advisors held 425 shares of scPharmaceuticals worth $4.33K as of Q2 2023.
  • scPharmaceuticals was a new BDO Wealth Advisors position in Q2 2023.
  • scPharmaceuticals made up ﹤0.01% of BDO Wealth Advisors's portfolio in Q2 2023, its #785 holding.
  • 81 funds tracked by Wall St. Rank held scPharmaceuticals as of Q2 2023.

Based on BDO Wealth Advisors's 13F filing for Q2 2023, filed 1 Aug 2023.